Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

BVMF/W2ST34 stock hub

BVMF/W2ST34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/W2ST34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

112.8B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/W2ST34

In the news

Latest news · BVMF/W2ST34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E37

P25 11.3P50 14.6P75 19.6

Trailing P/E39.8

P25 15.2P50 21.5P75 27.3

ROE19.1

P25 5.3P50 12.3P75 22.5

ROIC20

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/W2ST34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

219

Groups with data

Currency

USD

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	10,800
Employees Change	-600%
Employees Change Percent	-5.66
Enterprise value	BRL 111.8B
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Last refreshed	2026-05-10
Market cap	BRL 112.8B
Price	BRL 43.2
Price currency	BRL
Rev Per Employee	1,555,839.93x
Sector	Healthcare
Sic	3060
Symbol	bvmf/W2ST34
Website	https://www.westpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.51%
EV Earnings	39.49x
EV/EBIT	32.25x
EV/EBITDA	24.68x
EV/FCF	46.79x
EV/Sales	7.09x
FCF yield	2.12%
Forward P/E	37.03x
P/B ratio	7.23x
P/E ratio	39.83x
P/S ratio	6.71x
PE Ratio10 Y	44.62x
PE Ratio3 Y	42.93x
PE Ratio5 Y	42.63x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.52%
EBITDA Margin	27.01%
FCF margin	14.22%
Gross margin	36.28%
Gross Profit	BRL 6.1B
Gross Profit Growth	16.83%
Gross Profit Growth Q	27.81%
Gross Profit Growth3 Y	1.34%
Gross Profit Growth5 Y	6.01%
Net Income	BRL 2.8B
Net Income Growth	16.16%
Net Income Growth Q	54.57%
Net Income Growth3 Y	-0.57%
Net Income Growth5 Y	5.11%
Pretax Margin	21.26%
Profit Margin	16.85%
Profit Per Employee	BRL 262,140
ROA	11.21
Roa5y	12.28
ROCE	20.18
ROE	19.13
Roe5y	22.16
ROIC	19.97
Roic5y	27.23

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	28.05%
Cagr3y	-5.19%
Div CAGR3	6.14%
EPS Growth	17.39
EPS Growth Q	56.1
EPS Growth3 Y	0.88
EPS Growth5 Y	6.09
FCF Growth	49.23%
FCF Growth Q	-18.76%
FCF Growth3 Y	3.76%
FCF Growth5 Y	8.32%
OCF Growth	7.63%
OCF Growth Q	-30.53%
OCF Growth10 Y	12.65%
OCF Growth3 Y	0.21%
OCF Growth5 Y	7.25%
Revenue Growth	11.23x
Revenue Growth Q	21.05x
Revenue Growth3 Y	3.76x
Revenue Growth5 Y	6.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.83
Assets	BRL 21.4B
Cash	BRL 2.7B
Current Assets	BRL 9B
Current Liabilities	BRL 3.3B
Debt	BRL 1.7B
Debt EBITDA	BRL 0.35
Debt Equity	BRL 0.11
Debt FCF	BRL 0.7
Equity	BRL 15.6B
Interest Coverage	346.7
Liabilities	BRL 5.8B
Long Term Assets	BRL 12.5B
Long Term Liabilities	BRL 2.5B
Net Cash	BRL 1B
Net Cash By Market Cap	BRL 0.93
Net Cash Growth	107.02%
Net Debt EBITDA	BRL -0.23
Net Debt Equity	BRL -0.07
Net Debt FCF	BRL -0.44
Tangible Book Value	BRL 15B
Tangible Book Value Per Share	BRL 211
WACC	10.54

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.71
Inventory Turnover	4.88
Net Working Capital	BRL 3.4B
Quick ratio	1.81
Working Capital	BRL 6B
Working Capital Turnover	BRL 16.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.12%
Dividend Growth	-2.31%
Dividend Growth Years	2%
Dividend per share	BRL 0.09
Dividend Years	6
Dividend Yield	0.21%
Ex Div Date	2026-04-28
Last Dividend	BRL 0.02
Payout Frequency	Quarterly
Payout Ratio	11.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	28.03%
3Y total return	-14.78%
50-day SMA	38.35
All Time High	75.51
All Time High Change	-42.79%
All Time High Date	2021-12-28
All Time Low	30.7
All Time Low Change	40.72%
All Time Low Date	2022-11-03
ATR	1.87
Beta	1.17
Ch YTD	5.99
High	44.04
High52	48.04
High52 Date	2025-10-23
High52ch	-10.07%
Low	43.04
Low52	33.51
Low52 Date	2025-07-18
Low52ch	28.92%
Ma50ch	12.66%
RSI	60.06
RSI Monthly	49.16
RSI Weekly	48.14
Sharpe ratio	-0.04x
Sortino ratio	-0
Total Return	1.33%
Tr YTD	6.17
Tr1m	20.87%
Tr1w	-1.86%
Tr3m	22.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 3.6B
Operating Income Growth	16.19
Operating Income Growth Q	42.42
Operating Income Growth3 Y	-2.25
Operating Income Growth5 Y	6.08
Operating margin	21.52

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	70,136,813%
Net Borrowing	-5,897,040
Shares Insiders	0.61%
Shares Institutions	98.68%
Shares Qo Q	-0.41%
Shares Yo Y	-1.12%
Short Ratio	2.83

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 2.2B
Average Volume	119.35x
Bv Per Share	220
CAPEX	BRL -1.3B
Ch1m	20.81
Ch1w	-1.91
Ch1y	27.66
Ch3m	22
Ch3y	-15.29
Ch6m	-8.55
Change	-1.91%
Change From Open	-1.91
Close	44.04
Days Gap	0
Depreciation Amortization	867,847,720
Dollar Volume	734.4
Earnings Date	2026-04-23
EBIT	BRL 3.6B
EBITDA	BRL 4.5B
EPS	BRL 39.03
F Score	6
FCF	BRL 2.4B
FCF EV Yield	2.14x
Financing CF	-1,809,160,230
Fiscal Year End	December
Founded	1,923
Goodwill	536,630,640
Graham Number	12.07607
Graham Upside	-72.05
Income Tax	BRL 741.8M
Investing CF	-1,342,263,343
Is Primary Listing	0
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Lynch Fair Value	BRL 5.54
Lynch Upside	-87.18
Ma150	46.29
Ma150ch	-6.68%
Ma20	39.79
Ma20ch	8.57%
Net CF	611,400,170
Open	44.04
P FCF Ratio	47.2
P OCF Ratio	30.22
Payment Date	2026-05-12
Position In Range	16
Ppne	9,073,578,880
Price Date	2026-04-24
Price EBITDA	BRL 24.85
Ptbv Ratio	7.52
Relative Volume	0.14x
Revenue	16,803,071,225x
SBC By Revenue	0.9x
Share Based Comp	151,806,698
Tax By Revenue	4.41x
Tax Rate	20.76%
Tr6m	-8.4%
Volume	17
Z Score	12.65

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/W2ST34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.2%

$0.09 annual per share

Payout ratio

+11.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

2 consecutive years of growth

Total shareholder yield

+1.3%

Next ex-dividend date: 2026-04-28

Performance

BVMF/W2ST34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/W2ST34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+98.7%

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVMF/W2ST34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.1

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

1.17

Moves roughly with the market

Sharpe ratio

-0.04

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/W2ST34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/W2ST34 stock rating?

bvmf/W2ST34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/W2ST34 analysis?

The full report lives at /stocks/bvmf/W2ST34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/W2ST34?

The latest report frames bvmf/W2ST34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/W2ST34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.